Literature DB >> 16089240

Tonsillopharyngitis: clinical highlights.

Ted L Tewfik1, Mohamed Al Garni.   

Abstract

Tonsillopharyngitis is an extremely common infection seen in adults and children. Although the symptoms and signs of this disease are usually sufficient to make a diagnosis, it is often difficult to make a distinction between bacterial and viral etiology on clinical grounds alone. The complications of tonsillopharyngitis may be classified into suppurative and nonsuppurative complications. The nonsuppurative complications include scarlet fever, acute rheumatic fever, and post-streptococcal glomerulonephritis. Suppurative complications include peritonsillar, parapharyngeal, and retropharyngeal cellulites and/or abscess. Features suggestive of viral bacterial (GABHS) etiologies, the medical and surgical guidelines for managing tonsillopharyngitis, and its complications are highlighted in this article.

Entities:  

Mesh:

Year:  2005        PMID: 16089240

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  4 in total

1.  [Retropharyngeal inflammation presenting as meningitis: an important differential diagnosis in clinical neurology].

Authors:  J Kielhorn; T Liebig; P Berlit
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

2.  Efficacy of early dental and ENT therapy in preventing nephropathy in pediatric Henoch-Schönlein purpura.

Authors:  Chiyoko N Inoue; Takako Nagasaka; Sachiko Matsutani; Masako Ishidoya; Rikako Homma; Yasushi Chiba
Journal:  Clin Rheumatol       Date:  2008-07-24       Impact factor: 2.980

3.  Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies.

Authors:  Ping-Ping Lin; Chen-Jing Wang; Yan-Ping Liu; Ting Li; Xiao-Meng Gao; Ya-Ping Ma; Ping Shi; Xin Li; Le-Xin Wang; Yu Cao
Journal:  Adv Ther       Date:  2020-12-19       Impact factor: 3.845

4.  Population Pharmacokinetics of Cis-, Trans-, and Total Cefprozil in Healthy Male Koreans.

Authors:  Ji-Hun Jang; Seung-Hyun Jeong; Hea-Young Cho; Yong-Bok Lee
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.